Episode Details
Back to Episodes
Pharmaceutical Executive Daily: September 25, 2025
Published 7 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Glenmark’s billion-dollar exclusive licensing deal with Hengrui, Harmony Biosciences’ trial setback for Zygel, and the CDC’s unanimous vote to broaden COVID-19 vaccine recommendations.